In the current cohort, PD-L1+ve/high tumor cells were 24 (18%) cases, while combined PD-L1+ve/high tumor cells and TAIs were 33 (24%) cases, out of the studied HNSCC (Table 2). Here, CD274 is linked to neoplasm.